HIMSS21

PharmStars CEO Naomi Fried discusses how her company, through its PharmaU program, prepares digital health startups and pharma executives for successful partnerships.

There needs to be a bidirectional flow of social determinants of health data about a patient between healthcare systems and community organizations, says ProMedica's Sandy Lewallen.

AR Consultants Director Dr. Barry Newman discusses what's gone wrong with EHRs and how to get them back on the right course.

Clinical trials need to treat participants as people, not just data subjects, says Pluto Health CEO Dr. Joy Bhosai.

MatrixCare is using AI to stay ahead of the curve, says CTO John Weatherbie.

Sri Bharadwaj, VP of digital innovation at the Franciscan Alliance, explains why the telehealth and digital health innovations that were accelerated during the COVID-19 pandemic are here to stay.

Matthew Fisher, general counsel at Carium, discusses some bedrock principles of patient privacy, RPM advances, CMS rules around non-physiologic data and how telehealth should fit into the continuum of care going forward.

Using artificial intelligence to check medication histories helped limit face-to-face contact during the COVID-19 pandemic, explains Rebecca Sulfridge, clinical pharmacy specialist, emergency medicine, at Covenant HealthCare.

Amit Trivedi, director of Informatics & Health IT Standards at HIMSS, details three big trends he sees in health IT standards around public health, global health and the API economy.

Adobe's Tom Swanson and Anil Chakravarthy and CommonSpirit Health's Adam Rice discuss how healthcare organizations can use data to meet patients' needs for personalized service while following privacy regulations.